Synergetics USA Inc. (SURG) is gaining ground on FDA news. Shares are up $1.09, or 28 percent, to $4.94.
The company said it received 510(k) clearance from the U.S. Food and Drug Administration for VersaVIT, a novel vitrectomy system for the retinal surgery market.
"The entry of VersaVIT into the global vitrectomy market is a major milestone in Synergetics' strategy to enter into higher growth areas of retinal surgery," said David Hable, President and CEO.
The company is awaiting CE mark approval, which has been submitted and is currently under review.
Synergetics is a medical device company that makes innovative microsurgical devices for ophthalmic and neurosurgical applications.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.